| 1 | regulation of protein homooligomerization (GO:0032462) | 8.92504849 |
| 2 | T-helper 1 type immune response (GO:0042088) | 8.78044802 |
| 3 | protein targeting to peroxisome (GO:0006625) | 7.95281054 |
| 4 | establishment of protein localization to peroxisome (GO:0072663) | 7.95281054 |
| 5 | protein localization to peroxisome (GO:0072662) | 7.95281054 |
| 6 | lipopolysaccharide biosynthetic process (GO:0009103) | 7.53483733 |
| 7 | peroxisomal transport (GO:0043574) | 7.31775653 |
| 8 | histone H4-K12 acetylation (GO:0043983) | 7.20124153 |
| 9 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.96845904 |
| 10 | DNA deamination (GO:0045006) | 6.65662587 |
| 11 | lipopolysaccharide metabolic process (GO:0008653) | 6.59899377 |
| 12 | nucleotide transport (GO:0006862) | 6.15631534 |
| 13 | protein-cofactor linkage (GO:0018065) | 6.06920453 |
| 14 | rRNA catabolic process (GO:0016075) | 5.86977654 |
| 15 | positive regulation of isotype switching (GO:0045830) | 5.79256158 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.69880207 |
| 17 | negative regulation of glycogen biosynthetic process (GO:0045719) | 5.49204917 |
| 18 | intracellular protein transmembrane import (GO:0044743) | 5.42233314 |
| 19 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 5.29636661 |
| 20 | peroxisome organization (GO:0007031) | 5.24709390 |
| 21 | positive regulation of DNA recombination (GO:0045911) | 5.14617957 |
| 22 | spliceosomal snRNP assembly (GO:0000387) | 4.90003577 |
| 23 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 4.86022283 |
| 24 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.72098453 |
| 25 | positive regulation of interleukin-17 production (GO:0032740) | 4.67509793 |
| 26 | microtubule anchoring (GO:0034453) | 4.65180431 |
| 27 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.61494908 |
| 28 | regulation of protein oligomerization (GO:0032459) | 4.40047393 |
| 29 | microglial cell activation (GO:0001774) | 4.37343834 |
| 30 | negative regulation of glycogen metabolic process (GO:0070874) | 4.37202140 |
| 31 | adaptation of signaling pathway (GO:0023058) | 4.35640175 |
| 32 | negative regulation of telomere maintenance (GO:0032205) | 4.31297187 |
| 33 | negative regulation of cell killing (GO:0031342) | 4.25568856 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.25568856 |
| 35 | intracellular protein transmembrane transport (GO:0065002) | 4.20284677 |
| 36 | regulation of energy homeostasis (GO:2000505) | 4.17667836 |
| 37 | extracellular regulation of signal transduction (GO:1900115) | 4.15738231 |
| 38 | extracellular negative regulation of signal transduction (GO:1900116) | 4.15738231 |
| 39 | RNA methylation (GO:0001510) | 4.12650213 |
| 40 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.03754764 |
| 41 | keratan sulfate biosynthetic process (GO:0018146) | 4.00348154 |
| 42 | lysine metabolic process (GO:0006553) | 3.95521568 |
| 43 | lysine catabolic process (GO:0006554) | 3.95521568 |
| 44 | macrophage chemotaxis (GO:0048246) | 3.89001251 |
| 45 | platelet dense granule organization (GO:0060155) | 3.77780703 |
| 46 | positive regulation of mast cell activation (GO:0033005) | 3.64569746 |
| 47 | RNA capping (GO:0036260) | 3.57672120 |
| 48 | 7-methylguanosine RNA capping (GO:0009452) | 3.57672120 |
| 49 | positive regulation of mast cell degranulation (GO:0043306) | 3.56928101 |
| 50 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.56928101 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.55943767 |
| 52 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.53959194 |
| 53 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.51728782 |
| 54 | positive regulation of B cell mediated immunity (GO:0002714) | 3.51728782 |
| 55 | sleep (GO:0030431) | 3.48094864 |
| 56 | regulation of isotype switching (GO:0045191) | 3.46992830 |
| 57 | protein transmembrane transport (GO:0071806) | 3.45823757 |
| 58 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.44213953 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 3.39805943 |
| 60 | positive regulation of immunoglobulin production (GO:0002639) | 3.38553872 |
| 61 | histone H4-K5 acetylation (GO:0043981) | 3.38424854 |
| 62 | histone H4-K8 acetylation (GO:0043982) | 3.38424854 |
| 63 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.33619534 |
| 64 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.33305081 |
| 65 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.32893397 |
| 66 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.28000875 |
| 67 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.26187215 |
| 68 | membrane docking (GO:0022406) | 3.22727763 |
| 69 | thrombin receptor signaling pathway (GO:0070493) | 3.12915890 |
| 70 | keratan sulfate metabolic process (GO:0042339) | 3.08789829 |
| 71 | ribosome assembly (GO:0042255) | 3.08764609 |
| 72 | negative regulation of telomerase activity (GO:0051974) | 3.08024487 |
| 73 | sulfation (GO:0051923) | 3.04373850 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03823935 |
| 75 | ncRNA catabolic process (GO:0034661) | 3.00577828 |
| 76 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.90736461 |
| 77 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.89278125 |
| 78 | negative regulation of mast cell activation (GO:0033004) | 2.88959833 |
| 79 | glycerophospholipid catabolic process (GO:0046475) | 2.85728233 |
| 80 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.85386597 |
| 81 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.82054466 |
| 82 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.80390748 |
| 83 | termination of RNA polymerase III transcription (GO:0006386) | 2.79103566 |
| 84 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.79103566 |
| 85 | cellular protein complex disassembly (GO:0043624) | 2.78649356 |
| 86 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.71397527 |
| 87 | ribosomal small subunit assembly (GO:0000028) | 2.69507187 |
| 88 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.68719910 |
| 89 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.66339151 |
| 90 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.65707131 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.65707131 |
| 92 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.65041830 |
| 93 | T-helper cell differentiation (GO:0042093) | 2.65041830 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 2.64582664 |
| 95 | regulation of protein kinase A signaling (GO:0010738) | 2.61595265 |
| 96 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.61293711 |
| 97 | maturation of 5.8S rRNA (GO:0000460) | 15.8197312 |
| 98 | negative regulation of protein oligomerization (GO:0032460) | 12.4473934 |
| 99 | nucleotide transmembrane transport (GO:1901679) | 12.1826257 |
| 100 | protein import into peroxisome matrix (GO:0016558) | 11.6704795 |
RPL29P11 
